Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
36.26 USD | -0.03% | +9.83% | +71.28% |
May. 02 | Baird Starts Spyre Therapeutics With Outperform Rating, $50 Price Target | MT |
Apr. 19 | Sector Update: Health Care Stocks Steady Pre-Bell Friday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+71.28% | 1.46B | |
-2.00% | 103B | |
+6.91% | 101B | |
+4.28% | 23.07B | |
-11.61% | 22.23B | |
-4.87% | 18.05B | |
-39.98% | 17.18B | |
-11.46% | 16.94B | |
+5.96% | 14.07B | |
+36.54% | 12.35B |
- Stock Market
- Equities
- SYRE Stock
- News Spyre Therapeutics, Inc.
- Stifel Adjusts Price Target on Spyre Therapeutics to $27 From $23, Keeps Buy Rating